CHV (Catalyst Health Ventures) invests in transformative MedTech companies that are addressing global unmet healthcare needs and have the potential to become the new standard of care. Our thesis is exclusively focused on innovative early stage therapeutic devices, diagnostics and digital health solutions that significantly improve outcomes for patients, providers and payers.
25
Total Investments
12
Portfolio Companies
-
Exits
1
Industries
General Information
Industries
Health Care
Company Overview
About Catalyst Health Ventures
Recent Investments (25)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series B | •••••• | May 2024 | |
| Series C | •••••• | Apr 2024 | |
| Series B | •••••• | Feb 2024 | |
| Series A | •••••• | Mar 2022 | |
| Series A | •••••• | Feb 2022 | |
|
|
Series A | •••••• | May 2021 |
|
|
Series C | •••••• | Aug 2020 |
|
|
Series B | •••••• | Apr 2020 |
|
|
Series B | •••••• | Feb 2020 |
|
|
Series B | •••••• | Dec 2018 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.